Mesenteric Lymphangiography as a New Diagnostic and Therapeutic Tool for Refractory Chylous Lymphatic Leakages and Protein-Losing Enteropathy
🔍 **Clinical Question:**
Is mesenteric lymphangiography (mLAG) is technically feasible and clinically useful for patients with refractory chylous ascites, chylothorax, and protein-losing enteropathy (PLE)?
💡 **Key Insight:**
Mesenteric lymphangiography (mLAG), via a percutaneous or intraoperative approach, is technically feasible and safe.
The utility of mLAG is in imaging the blind spots of conventional lymphatic studies, especially for chylous ascites and protein-losing enteropathy, and it allows for embolization of mesenteric lymphatics.
👉 **Why it matters:**
mLAG is technically feasible and safe. It can be a useful tool to image the mesenteric lymphatics or perform mesenteric lymphatic embolization.
➡️ **Full Article:**
https://doi.org/10.1016/j.jvir.2025.08.008
#InterventionalRadiology #Lymphangiography #ChylousAscites #LymphaticIntervention #MedEd
#InterventionalRadiology #Lymphangiography #ChylousAscites #LymphaticIntervention #MedEd
